Biological indices in the assessment of breast cancer.
作者信息
Leong A S, Lee A K
机构信息
Division of Tissue Pathology, Institute of Medical and Veterinary Science and Department of Pathology, University of Adelaide, Adelaide, South Australia.
出版信息
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
Abstract
摘要
相似文献
1
Biological indices in the assessment of breast cancer.
Clin Mol Pathol. 1995 Oct;48(5):M221-38. doi: 10.1136/mp.48.5.m221.
2
Can diffusion tensor anisotropy indices assist in breast cancer detection?
J Magn Reson Imaging. 2016 Dec;44(6):1624-1632. doi: 10.1002/jmri.25292. Epub 2016 Apr 19.
3
Fatigue screening in breast cancer patients: identifying likely cases of cancer-related fatigue.
Psychooncology. 2016 Mar;25(3):275-81. doi: 10.1002/pon.3907. Epub 2015 Jul 22.
4
The Clinical Importance of Measurement of Hematological Indices in the Breast Cancer Survivals: A Comparison Between Premenopausal and Postmenopausal Women.
World J Oncol. 2016 Feb;7(1):1-4. doi: 10.14740/wjon956e. Epub 2016 Apr 3.
5
6
Prognostic immune-related gene models for breast cancer: a pooled analysis.
Onco Targets Ther. 2017 Sep 11;10:4423-4433. doi: 10.2147/OTT.S144015. eCollection 2017.
7
Immunohistochemical Ki-67/KL1 double stains increase accuracy of Ki-67 indices in breast cancer and simplify automated image analysis.
Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):568-76. doi: 10.1097/PAI.0b013e3182a84b99.
8
Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients.
J Cancer Res Clin Oncol. 2009 Feb;135(2):319-23. doi: 10.1007/s00432-008-0462-7. Epub 2008 Aug 29.
9
Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data.
J Nucl Med. 2017 Mar;58(3):387-392. doi: 10.2967/jnumed.116.181859. Epub 2016 Oct 6.
10
Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).
Mol Biol Rep. 2019 Apr;46(2):2013-2027. doi: 10.1007/s11033-019-04650-9. Epub 2019 Jan 31.
引用本文的文献
1
Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria.
World J Clin Oncol. 2020 Nov 24;11(11):935-944. doi: 10.5306/wjco.v11.i11.935.
2
The changing role of pathology in breast cancer diagnosis and treatment.
Pathobiology. 2011;78(2):99-114. doi: 10.1159/000292644. Epub 2011 Jun 14.
本文引用的文献
1
Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study.
Breast Cancer Res Treat. 1993;25(1):21-7. doi: 10.1007/BF00662397.
2
In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index.
Int J Cancer. 1993 Jun 19;54(4):531-5. doi: 10.1002/ijc.2910540402.
3
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965.
4
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours.
Eur J Cancer. 1993;29A(6):881-6. doi: 10.1016/s0959-8049(05)80431-9.
5
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
Nature. 1993 Apr 29;362(6423):857-60. doi: 10.1038/362857a0.
6
A linkage study in seven breast cancer families.
Am J Hum Genet. 1993 Apr;52(4):786-8.
7
Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21.
Am J Hum Genet. 1993 Apr;52(4):767-76.
8
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.
Am J Hum Genet. 1993 Apr;52(4):718-22.
9
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Cancer Res. 1993 Apr 1;53(7):1637-41.
10
Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
Oncogene. 1993 Feb;8(2):279-88.
Zotero 插件